1. Introduction
Alginate hydrogels have been extensively studied as drug delivery matrices owing to their mild ionic gelation conditions, excellent biocompatibility, and tunable mechanical properties [
1,
2]. Alginate, an anionic polysaccharide derived from brown algae, forms a three-dimensional cross-linked network via ion exchange with multivalent cations such as Ca
2+, following the well-known “egg-box” model. This process provides high water content, interconnected porous networks, and favorable drug-loading capacity [
1,
3,
4]. Owing to these characteristics, alginate has found broad use in wound dressings, cell encapsulation, and localized drug delivery [
2,
5].
However, alginate hydrogels inherently suffer from rapid initial burst release of hydrophilic, low-molecular-weight drugs, attributable to their high water content and large pore architecture [
4,
6,
7]. Water-soluble small-molecule drugs concentrated at or near the carrier surface are rapidly eluted within minutes upon immersion. This can cause local tissue toxicity, failure to maintain therapeutic drug levels, and poor reproducibility during formulation development [
6,
8,
9]. Huang and Brazel [
6] systematically reviewed that initial burst is determined by multiple factors including (1) high surface-area-to-volume ratio in small particles, (2) pore structure and boundary-layer diffusion, (3) insufficient drug–gel network interactions, and (4) concentration gradients and drying/rehydration history during fabrication.
Various strategies have been proposed to address the burst release problem. The most fundamental approaches involve modifying the matrix properties through alginate concentration and mannuronic-to-guluronic acid (M/G) ratio adjustment, or Ca
2+ concentration optimization [
1,
4]. Complex gel formation with chitosan or poly-L-lysine, surface coating via layer-by-layer (LbL) deposition, and core–shell structure design have also been reported [
10,
11,
12]. In particular, polymeric diffusion barriers introduced through coating enable release control that is difficult to achieve with a single matrix. Staged release patterns can be realized by independently designing the composition, thickness, and function of each layer [
10,
13].
Hierarchical multilayer structures arrange materials of differing permeability in series. This configuration offers a practical route to stepwise diffusion regulation by controlling both hydration pathways and diffusion rates [
10,
13,
14]. Similar multilayer barrier principles operate in biological tissues: the stratum corneum–epidermis–dermis architecture of skin controls bidirectional molecular transport [
15], and the intima–media–adventitia tri-layer of blood vessel walls governs selective permeation [
16]. These natural examples have spurred interest in multilayer barrier design for drug delivery. Yet systematic application of hierarchical coating strategies to hydrogel carriers with direct comparison across particle scales has received little attention.
Poly(lactic-co-glycolic acid) (PLGA) is one of the most widely used biodegradable drug delivery polymers, supported by its FDA-approval history and extensive clinical experience [
17,
18]. PLGA degrades through hydrolysis of ester bonds, with degradation rates tunable from weeks to months depending on the lactide: glycolide molar ratio [
17,
19]. However, neat PLGA coatings excessively suppress moisture and ion permeation due to their high hydrophobicity. This can over-retard hydrogel core swelling and delay drug release until PLGA degradation onset, producing “long-term depot” behavior [
18,
20].
To overcome this limitation, blending poly(ethylene glycol) (PEG) with PLGA has been proposed [
21,
22]. PEG is widely known as a hydrophilic polymer with excellent water solubility and low protein adsorption [
21,
23]. Within PLGA matrices, PEG phase-separates to form hydrophilic channels (hydrated domains), thereby imparting moisture permeability [
22,
24]. Accordingly, PLGA/PEG blend coatings can realize a “semi-permeable barrier” that provides higher moisture and ion permeability than PLGA alone while maintaining hydrophobic diffusion barrier function. This makes them well suited for targeting short-term controlled release [
22,
24,
25].
Particle scale is a critical variable governing drug release kinetics. Even for hydrogels of identical composition and structure, macroscale beads (~1 mm) and microscale microgels (~100 µm) differ by approximately 10-fold in surface-area-to-volume (SA/V) ratio. This leads to substantially different hydration rates, ion-exchange kinetics, and burst release magnitudes [
4,
26]. Because microgels hydrate and release drug much faster owing to their high SA/V ratio, a single coating strategy is unlikely to perform equally at both scales. However, systematic comparison of such scale-dependent release behavior in relation to barrier structure design remains insufficient [
4,
26,
27]. Existing alginate coating approaches—chitosan complexation, polyelectrolyte LbL deposition, and single-polymer shell formation—have been applied at a fixed particle scale, and the relationship between barrier architecture and scale has not been addressed [
10,
11,
12].
Thus, the aim of the current study was to clarify how particle scale and barrier architecture jointly govern short-term release kinetics when PLGA/PEG blend-based hierarchical barriers are applied to alginate hydrogels (
Scheme 1). An overview of the full experimental workflow, including fabrication, coating, and characterization, is presented in
Scheme 2. To this end, Ca
2+-ionically cross-linked alginate cores were used as a common platform, and PLGA/PEG barriers were applied at two distinct length scales: macroscale beads (~1 mm) and microscale microgels (~100 µm). Beads received PLGA/PEG multilayer dip-coating (3 cycles); microgels received either a single PLGA/PEG coating or an additional PLGA shell to form a double-barrier structure. Core–shell formation was verified by CLSM, SEM/EDS, FT-IR, and XPS, while coating stability was tracked by TGA over 1–9 days. Using L-ascorbic acid as a model drug, in vitro release testing, combined with mass-based swelling (dQ/dt) analysis, showed that the dominant release-control mechanism shifts from swelling-dominated to diffusion-barrier-dominated as particle scale decreases. We also applied a vacuum re-loading process and confirmed that it improves encapsulation efficiency (EE). Together, these findings provide a design framework for scale-customized, burst-buffered short-term controlled release from hydrogel carriers.
2. Materials and Methods
2.1. Materials
Sodium alginate (alginic acid sodium salt, medium viscosity, Sigma-Aldrich, St. Louis, MO, USA), calcium chloride dihydrate (CaCl2 2H2O, ≥99%, Sigma-Aldrich), poly(D,L-lactide-co-glycolide) (PLGA, lactide:glycolide = 75:25, Mw ~10 kDa, Sigma-Aldrich), poly(ethylene glycol) (PEG, Mw ~8 kDa, Sigma-Aldrich), dichloromethane (DCM, ≥99.5%, Sigma-Aldrich), L-ascorbic acid (vitamin C, ≥99%, Sigma-Aldrich), FITC-dextran (70 kDa, Sigma-Aldrich), Nile Red (Sigma-Aldrich), poly(vinyl alcohol) (PVA, Mw ~31 kDa, 98–99%-hydrolyzed, Sigma-Aldrich), and phosphate-buffered saline (PBS, pH 7.4) were used. All reagents were used as received without further purification, and deionized water (18.2 MΩ cm) was used throughout the experiments.
2.2. Alginate Hydrogel Core Fabrication
2.2.1. Macroscale Bead (~1 mm) Fabrication
Alginate aqueous solution (1–5% w/v; primary experimental group: 4% w/v) was dispensed dropwise into 100 mM CaCl2 solution using a syringe (21G needle) to induce external ionotropic gelation. Dispensed droplets were allowed to cure in the CaCl2 solution for 10–15 min, followed by two washes with PBS (+0.01% Tween-20) to remove residual Ca2+ and unreacted alginate. Bead diameters were measured using a digital caliper and confirmed to be approximately 1 mm (+/−0.1 mm, n = 30).
2.2.2. Microscale Microgel (~100 µm) Fabrication
Alginate aqueous solution (2% w/v) was dispersed into 100 mM CaCl2 solution via high-shear external gelation, followed by fractionation through a micro-sieve (100 µm mesh) to ensure narrow size distribution. Laser diffraction particle size analysis yielded a median diameter (D50) of approximately 100 µm with a span value of 1.0–1.5, indicating a relatively uniform particle size distribution.
2.3. PLGA/PEG Blend Dip-Coating
PLGA (75:25, 10 kDa) and PEG (8 kDa) were dissolved in DCM:acetone (3:1
v/
v)-mixed solvent to prepare blend coating solutions. The PLGA:PEG weight ratio was selected at 7:3 based on preliminary screening of macroscopic phase behavior across four compositions (6:4, 7:3, 8:2, and 9:1
w/
w). Visual assessment revealed phase separation at the 6:4, 8:2, and 9:1 ratios, whereas only the 7:3 blend maintained acceptable phase compatibility with sufficient PEG content for hydrophilic channel formation (
Figure S1). Total polymer concentration was fixed at 5 wt%.
For beads, Ca2+-alginate beads were immersed in the coating solution for 2 s, withdrawn, air-dried for 1 min at room temperature, and restabilized in 10 mM CaCl2 for 2 min; this sequence constituted one cycle, and three cycles were repeated to form multilayer coatings. For microgels, only one cycle was applied to prevent inter-particle bridging and aggregation.
2.4. Double-Barrier Microgel Fabrication (Additional PLGA Shell)
The double-barrier structure was fabricated using PLGA/PEG-coated microgels as precursors. These were dispersed in PLGA 5% (w/v) in DCM solution, and the PLGA shell was formed on the microgel exterior through solvent extraction/evaporation into 1% (w/v) PVA aqueous solution (~300 rpm, 30 min, room temperature). The final product was a tri-layer core–shell system comprising alginate core/PLGA-PEG inner layer/PLGA outer layer.
2.5. Coating Visualization and Chemical Verification
2.5.1. CLSM (Confocal Laser Scanning Microscopy)
A dual-fluorescence labeling strategy was used to visualize the spatial distribution of the core–shell structure. The alginate core was labeled with FITC-dextran (70 kDa, 0.05% w/v), and the PLGA/PEG coating layer was labeled with Nile Red (1–2 mg/mL in DCM:acetone). Images were acquired on a Zeiss LSM800 (Carl Zeiss, Oberkochen, Germany) using sequential scan mode for FITC (ex/em: 488/515–540 nm) and Nile Red (ex/em: 561/600–650 nm) to prevent inter-channel crosstalk. Image processing and analysis were performed using ImageJ v1.54g (National Institutes of Health, Bethesda, MD, USA).
2.5.2. SEM/EDS
Surface morphology and elemental composition of uncoated and PLGA/PEG-coated specimens were analyzed by field-emission scanning electron microscopy (FE-SEM; S-4800, Hitachi, Tokyo, Japan) equipped with energy-dispersive X-ray spectroscopy (EDS). Specimens were washed with deionized water, freeze-dried, mounted on aluminum stubs, and sputter-coated with platinum (~10 nm). SEM images were acquired at an accelerating voltage of 5 kV. Changes in carbon (C) and oxygen (O) atomic percentages and O/C ratios from EDS were used as indicators of coating layer formation.
2.5.3. FT-IR
Fourier-transform infrared (FT-IR) spectra were acquired on a Nicolet iS50 spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an ATR accessory (diamond crystal). Spectra of uncoated and PLGA/PEG-coated specimens (freeze-dried) were recorded over the 4000–400 cm−1 range at 4 cm−1 resolution with 32 scans co-added. Analysis focused on (i) preservation of the alginate ionic cross-linked network (-COO- bands, ~1600–1650, and ~1400–1450 cm−1) and (ii) introduction of PLGA/PEG organic coating (PLGA C=O ~1750 cm−1, PEG C-O-C ~1100 cm−1). Peak deconvolution of the C 1s spectra was performed using CasaXPS v2.3.25 (Casa Software Ltd., Teignmouth, UK).
2.5.4. XPS
X-ray photoelectron spectroscopy (XPS) was performed using a K-Alpha+ spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) with a monochromatic Al K-alpha X-ray source (1486.6 eV). Survey spectra and high-resolution C 1s, O 1s, and Ca 2p spectra were acquired at pass energies of 200 eV and 50 eV, respectively. High-resolution C 1s spectra were deconvoluted to determine relative area ratios of C-C/C-H (284.8 eV) and C-O (286.3 eV) components. Changes in the C-C/C-H fraction and C 1s FWHM were used as indicators of PLGA/PEG coating introduction.
2.6. Thermogravimetric Analysis (TGA) for Coating Retention
PLGA/PEG-coated beads and microgels were stored in PBS (37 °C) and retrieved at days 1, 3, 5, 7, and 9 for thermogravimetric analysis (TGA; Q500, TA Instruments, New Castle, DE, USA). TGA was conducted under Ar atmosphere over 25–800 °C at a heating rate of 10 °C/min. Mass loss in the 200–400 °C range (∆W 200–400) was attributed to thermal decomposition of the PLGA/PEG organic coating, and the coating contribution was isolated by subtracting the 200–400 °C mass loss of uncoated controls under identical conditions. Coating retention (%) was calculated by normalizing each time point’s ∆W 200–400 value to the day 1 baseline (n = 5). Thermograms were analyzed using TA Universal Analysis v4.5A (TA Instruments, New Castle, DE, USA).
The 9-day monitoring period was chosen to verify coating stability well beyond the intended short-term release window (minutes to hours). Beyond 9 days, both beads and microgels underwent visible structural disintegration under physiological conditions (PBS, 37 °C), precluding further sampling (
Figure S2).
2.7. Swelling Ratio and Initial Swelling Rate (dQ/dt) Measurement
Mass-based swelling ratio (Qt) was measured as a function of time for uncoated and PLGA/PEG-coated beads (~1 mm) and microgels (~100 µm). Specimens were immersed in PBS (pH 7.4, 37 °C, 100 rpm) and retrieved at predetermined time intervals (0, 5, 10, 20, 30, 60, 120, 180, 240, and 300 min); surface free water was removed by blotting, and mass (Wt) was measured immediately. Swelling ratio was defined as Qt (%) = (Wt − Wdry)/Wdry × 100. The initial swelling rate dQ/dt was calculated by finite difference between adjacent time points, and the first-interval rate (dQ/dt) (i.e., 0–5 min) was used to compare initial hydration suppression effects between uncoated and coated groups (n = 5). The 0–5 min interval was selected because it captures the steepest phase of hydration, during which the coating barrier effect is most pronounced and burst release is most rapid.
2.8. In Vitro Release Testing
L-ascorbic acid (vitamin C, Mw 176.12 Da) was selected as the model drug. As a highly water-soluble, low-molecular-weight hydrophilic molecule, L-ascorbic acid represents the “worst-case” burst release scenario in hydrogel matrices, exhibiting the fastest diffusion and maximum initial burst among candidate payloads [
28,
29]. Validating barrier efficacy under such extreme burst conditions provides the most stringent assessment of the coating strategy. If meaningful burst suppression is achieved, equivalent or superior performance can be anticipated for drugs of higher molecular weight or greater hydrophobicity.
2.8.1. Beads: Uncoated vs. PLGA/PEG-Coated (2 Groups)
L-ascorbic acid (100 mM) was loaded into 4% (w/v) alginate beads via post-gelation soaking, and release tests were conducted in a two-group comparative design: uncoated vs. PLGA/PEG multilayer-coated (3 cycles). Release testing was performed in PBS (pH 7.4, 37 °C, 100 rpm) with complete medium replacement at predetermined intervals to maintain sink conditions. Sink volume was maintained at ≥50 mL per gram of gel; even at complete drug release, the resulting concentration would remain below 0.003% of L-ascorbic acid aqueous saturation solubility (~330 mg/mL at 20 °C), well within the conventional sink criterion. L-ascorbic acid concentration was quantified by UV-Vis spectrophotometry (V-550, JASCO Corporation, Tokyo, Japan) at 265 nm. Cumulative release (%) was calculated (n = 5).
2.8.2. Microgels: Uncoated/PLGA/PEG-Coated/Double-Barrier (3 Groups)
Microgel-based release testing was designed as a three-group comparison: (i) uncoated microgels, (ii) PLGA/PEG single-barrier microgels, and (iii) PLGA/PEG + PLGA shell double-barrier microgels. L-ascorbic acid (100 mM) was loaded under identical conditions. Release conditions were the same as for beads: PBS (pH 7.4, 37 °C, 100 rpm), with UV-Vis quantification and cumulative release comparison (n = 5).
2.9. Model Drug Loading and Vacuum Re-Loading Process
Basic loading was performed by post-gelation soaking of prepared Ca2+-alginate beads and microgels in L-ascorbic acid (100 mM) aqueous solution for 2 h at room temperature. Vacuum re-loading was applied after basic loading: gels immersed in drug solution were subjected to an air-pressurized vacuum process (−85 to −90 kPa followed by return to 1 atm, 5 min/cycle, 3 cycles total) to remove residual gas from internal pores and induce convective drug penetration driven by the pressure differential. Encapsulation efficiency (EE) was defined as EE (%) = (Mactual/Mtheoretical) × 100, and Mactual was determined from UV-Vis absorbance changes in the supernatant before and after loading (n = 5).
2.10. Statistical Analysis
All quantitative data were obtained from independent replicates (n = 5) and expressed as mean +/− standard deviation (SD). For two-group comparisons (beads: uncoated vs. coated), statistical significance was determined by Student’s t-test. For three-group comparisons (microgels: uncoated vs. single-barrier vs. double-barrier), one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test was used. Significance was set at p < 0.05 for all analyses. All statistical analyses were performed using IBM SPSS Statistics v26.0 (IBM Corp., Armonk, NY, USA).
4. Discussion
4.1. Redefining the Role of PLGA/PEG Coating: “Early-Burst Buffer”
The release data indicate that the PLGA (75:25)/PEG (8 kDa) blend coating does not act as a month-scale long-term depot. Instead, it serves as an “early-burst buffer” that slows the initially rapid hydration, swelling, and diffusion over several hours. Three observations support this interpretation. First, coated and uncoated beads converge to near-complete release within 24 h. Second, the coating behaves as a semi-permeable rather than impermeable barrier—it retards but does not block hydration and ion exchange. Third, TGA retention remains at ~70–80% after 9 days, confirming that the coating stays physically intact over the short term.
This behavior reflects the PLGA/PEG blend ratio (7:3
w/
w): PEG domains create hydration channels that raise coating permeability well above that of neat PLGA [
22,
24]. The PLGA continuous phase still provides hydrophobic diffusion resistance, but the PEG dispersed phase lets moisture and ions partially penetrate. The overall coating therefore acts as a ‘gradual attenuation’ barrier rather than an ‘on/off’ blockade, suited to short-term controlled release on the hours-to-one-day timescale [
24,
25]. In vivo pharmacokinetic parameters were not assessed in the present study. Nevertheless, this hour-scale attenuation of the initial burst may be relevant for drugs with a narrow therapeutic index, where moderating the early release peak could help limit dose-dumping-associated toxicity.
For context, representative data from the literature show a range of burst-release outcomes with alginate-based coating strategies: a chitosan/alginate hydrogel released ~35% of hydrocortisone and ~65% of sulfasalazine within 1 h, with the difference attributable to drug hydrophilicity [
30]; five-layer LbL-coated alginate beads sustained ATP release over 14 days [
31]; and nano-coated alginate hydrogels eliminated VEGF burst entirely [
32]. Our bead results (~60% at 1 h) fall in the mid-range for single-strategy coatings applied to hydrophilic small molecules, while the double-barrier microgel results (<10% at 10 min) are competitive with multilayer approaches.
4.2. Scale-Dependent Release Mechanism Transition
The same PLGA/PEG coating strategy engaged different release control mechanisms depending on particle scale.
In mm-scale beads, PLGA/PEG multilayer coating alone simultaneously reduced initial swelling rate and burst release by approximately 50%. This parallel suppression is consistent with a “swelling-dominated burst control” mechanism: at the relatively low SA/V ratio of beads, hydration delay by the coating directly translates to release suppression. The coating retards water and ion influx, slowing network swelling and ion exchange, thereby producing a cascade of reduced pore expansion and drug diffusion.
In contrast, for µm-scale microgels, PLGA/PEG single coating reduced the initial swelling rate by a similar proportion, yet burst release did not decrease proportionally. The high SA/V ratio of microgels (~10× that of beads) apparently overwhelms swelling suppression alone, allowing rapid diffusion across the large total surface. When a PLGA shell was added to form a double barrier, however, burst dropped sharply—evidence that the dominant release-control factor shifted from “swelling rate” to “diffusion resistance.” This shift is consistent with a series diffusion-resistance models: in core–shell structures, the effective mass transfer coefficient (k
eff) scales as 1/k
eff ~ sum(δ
i/D
i), where δ
i and D
i are each layer’s thickness and diffusion coefficient, respectively [
13]. Even a thin PLGA shell with a low diffusion coefficient can therefore raise total diffusion resistance considerably.
Microgels were prepared at 2% (w/v) alginate, producing a less dense network than the 4% (w/v) beads. Despite this lower matrix density, double-barrier microgels achieved the strongest burst suppression among all groups, indicating that barrier layer resistance, not matrix density, is the dominant factor at this scale.
We note that this proposed mechanism transition from swelling-dominated to diffusion-barrier-dominated control is inferred from the convergence of swelling and released data across two particle scales, rather than directly measured through independent decoupling experiments. Definitive verification using non-swelling matrices as controls remains an important direction for future work.
4.3. Structural Analogy with Natural Multilayer Barrier Systems
The hierarchical barrier structure implemented in this study shares structural and functional similarity with multilayer diffusion-regulation systems observed in nature. In biological tissues, molecular transport is often regulated in a stepwise manner by serial arrangement of multiple layers with different permeabilities rather than by a single homogeneous membrane [
15,
16]. For example, the stratum corneum of skin, composed of highly hydrophobic ceramide-lipid matrix, primarily blocks external substance penetration. The underlying viable epidermis and dermis secondarily regulate diffusion within a hydrophilic matrix [
15]. This alternating arrangement of hydrophobic and hydrophilic layers enables selective, stepwise transport control that is difficult to achieve with a single homogeneous barrier.
In our double-barrier microgels, the tri-layer structure of (i) alginate core (high permeability, hydrophilic), (ii) PLGA/PEG inner layer (intermediate permeability, semi-permeable), and (iii) PLGA shell outer layer (low permeability, hydrophobic) mirrors this natural “graded-permeability” principle. The outermost hydrophobic PLGA shell creates a “hydration induction period” that delays core hydration, while the inner PLGA/PEG semi-permeable membrane continues to modulate drug diffusion even after water reaches it. This dual mechanism functionally parallels the hierarchical role division where the stratum corneum delays initial moisture penetration and the underlying tissue regulates subsequent diffusion. This comparison is intended as a structural/functional analogy, not an experimentally quantified equivalence. Measuring independent permeation coefficients for each synthetic layer and comparing them with published biological barrier data remains to be done.
4.4. Practical Significance of Vacuum Re-Loading
While post-gelation soaking is straightforward, EE is limited by residual bubbles and pore accessibility constraints within the gel. The vacuum re-loading process introduced in this study operates by (1) removing residual gas from the gel interior during depressurization and (2) inducing convective drug penetration driven by the pressure differential during repressurization [
33]. The resulting EE values were ~51% for beads and ~23% for microgels, corresponding to relative gains of >50% and >20%, respectively. Gel morphology and mechanical stability were maintained after the process. For context, post-gelation soaking of alginate beads with hydrophilic small molecules typically yields EE in the 20–50% range [
4,
6]; the EE values obtained here are therefore within the expected range for this loading method. The PLGA/PEG coating is applied after drug loading and does not restrict EE; its role is to modulate release kinetics, not loading capacity.
4.5. Limitations and Future Directions
This study is limited to a single hydrophilic, low-molecular-weight model drug, L-ascorbic acid (Mw 176 Da). However, L-ascorbic acid represents the worst-case burst release scenario in hydrogel matrices [
28,
29]; thus, the barrier efficacy observed here can be viewed as a conservative estimate. Whether this barrier strategy extends to drugs of higher molecular weight (1–50 kDa) or different polarities remains to be tested. Charged biomolecules may interact electrostatically with the anionic alginate network, adding complexity not addressed in this study.
Coating thickness and surface roughness were not directly quantified in this study. Alginate hydrogels contain >90% water, and the shrinkage caused by dehydration during sample preparation precludes reliable cross-sectional dimensional measurements. Instead, coating retention was tracked over 9 days by TGA (
Table 2). Cryo-SEM/FIB or environmentally controlled AFM in the hydrated state would be required to obtain accurate thickness and roughness data, and this remains a priority for future work. Coating microstructure after vacuum cycling was not examined in this study; whether repeated pressure cycling affects coating continuity at the sub-surface level warrants investigation in future work.
In vivo release testing and cytotoxicity evaluation were beyond the scope of this study, which focused on establishing fundamental structure–property–release relationships. Given the established biocompatibility profiles of PLGA [
17,
18], PEG [
21], and alginate [
1,
2], the next steps would include cytotoxicity testing (ISO 10993-5-based MTT/CCK-8 assay [
34]), tissue compatibility evaluation, and in vivo pharmacokinetic studies [
35]. Based on the particle sizes and release characteristics, plausible application spaces include injectable local-delivery depots (microgels), oral systems requiring burst control during gastric transit (beads), and implantable hydrogel matrices for wound or surgical sites. Independent measurement of each layer’s permeation coefficient and fitting to multi-compartment diffusion models would enable quantitative mechanistic verification [
36,
37]. Stimuli-responsive coatings that offer selective, adaptive permeation control are also worth exploring [
38].
5. Conclusions
We applied PLGA/PEG blend-based hierarchical barriers to Ca2+-cross-linked alginate beads (~1 mm) and microgels (~100 µm) and asked how particle scale and barrier architecture govern short-term release kinetics.
Complementary analyses by CLSM, SEM/EDS, FT-IR, and XPS confirmed core–shell structure formation and Ca2+-alginate network preservation in both beads and microgels upon PLGA/PEG coating. TGA showed coating retention of approximately 73% (beads) and 79% (microgels) after 9 days in PBS at 37 °C, sufficient for short-term applications.
The PLGA/PEG coating acted not as a complete long-term release depot but as an “early-burst buffer,” reducing 1 h burst from >85% to ~60% in beads while allowing near-complete release within 24 h.
The release data revealed a scale-dependent transition in the dominant control mechanism. In mm-scale beads, the coating suppressed swelling and burst in parallel, indicating swelling-dominated control. In µm-scale microgels, swelling suppression alone could not overcome the high SA/V ratio; only the double-barrier structure with an additional PLGA shell shifted control to diffusion-barrier-dominated release, limiting 10 min release to <10% and 60 min release to ~30–40%.
Vacuum re-loading raised EE from ~32% to ~51% for beads and from ~18% to ~23% for microgels without damaging gel structure.
Hierarchical PLGA/PEG barrier engineering, when tailored to particle scale, can thus serve as a workable route to burst-buffered short-term controlled release on the minutes-to-hours timescale.